ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Universidad Politécnica de Valencia
Valencia, EspañaUniversidad Politécnica de Valencia-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2024
-
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer
Cell Death Discovery, Vol. 10, Núm. 1
2023
-
Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies
Cancers, Vol. 15, Núm. 18
-
Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy
ACS Applied Materials and Interfaces, Vol. 15, Núm. 32, pp. 38323-38334
-
High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
International journal of molecular sciences, Vol. 24, Núm. 4
-
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast Cancer
Cancers, Vol. 15, Núm. 7
2022
2021
-
Nanoporous Anodic Alumina-Based Sensor for miR-99a-5p Detection as an Effective Early Breast Cancer Diagnostic Tool
ACS Sensors, Vol. 6, Núm. 3, pp. 1022-1029